跳至主導覽 跳至搜尋 跳過主要內容

Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)

研究成果: 雜誌貢獻文章同行評審

3   連結會在新分頁中開啟 引文 斯高帕斯(Scopus)

摘要

In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

原文英語
文章編號241
頁(從 - 到)241
期刊Frontiers in Endocrinology
10
發行號APR
DOIs
出版狀態已發佈 - 2019

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG 3 - 良好的健康和福祉
    SDG 3 良好的健康和福祉

ASJC Scopus subject areas

  • 內分泌學、糖尿病和代謝

指紋

深入研究「Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)」主題。共同形成了獨特的指紋。

引用此